FDA 483 - Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - May 03, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Wyeth Biopharma Division of Wyeth Pharmaceuticals Inc. in Andover, MA, received a Form 483 for significant deficiencies in manufacturing controls, facility maintenance, and pest control. Observations included failures to follow written procedures, inadequate facility and equipment upkeep with multiple leaks and structural issues, and ineffective corrective actions for a persistent drain fly infestation. These issues indicate a lack of control over drug substance manufacturing and potential contamination risks.
- Inspection Date
- May 3, 2019
- Product Type
- Drugs
ID · f5c92731-0fa2-4ec9-acaf-b10ee4f44051